ORASURE TECHNOLOGIES INC
For the period ended Dec 31, 2025. Filed Apr 30, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 31, 2025 · Filed Apr 30, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Filed by the Registrantx Filed by a Party other than the Registranto
Check the appropriate box:
| o | Preliminary Proxy Statement |
|---|---|
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| x | Definitive Proxy Statement |
| o | Definitive Additional Materials |
| o | Soliciting Material under §240.14a-12 |
OraSure Technologies, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| x | No fee required. |
|---|---|
| o | Fee paid previously with preliminary materials |
| o | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Proxy StatementNotice of Annual Meeting of Stockholders
2026 Wednesday, June 3, 2026 • 9:00 a.m. (Eastern Time)
Letter to the Stockholders
| Carrie Eglinton MannerChief Executive Officer (“CEO”) and President | April 30, 2026Dear Fellow Stockholders:On behalf of the Board of Directors, we invite you to attend the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of OraSure Technologies, Inc. on Wednesday, June 3, 2026 at 9:00 a.m. (Eastern Time). This year’s Annual Meeting will be held virtually via a live webcast. You will be able to attend online, and ask your questions during the meeting by visiting http://www.cesonlineservices.com/osur26_vm. 2025 marked OraSure's 25th year as a public company. Since the beginning, we have been guided by a clear vision to transform health through actionable insights. This purpose continues to drive our efforts to decentralize diagnostics and connect people to healthcare wherever they are. OraSure built strong momentum through the year as we continued to execute our strategy and establish a foundation for long-term success and value creation:•We achieved key pipeline milestones, including FDA submissions for our SherlockTM CT/NG rapid molecular self-test and Colli-PeeTM urine self-collection device for STI indications in December 2025, both of which support expected commercialization and revenue realization in 2026.•We took meaningful steps to enhance our operations by improving our cost structure, leveraging our manufacturing capabilities and capacity, expanding our margin potential, and maintaining a strong balance sheet with financial flexibility to pursue both organic and inorganic growth initiatives. •We actively returned capital to shareholders, including initiating a $40 million share repurchase program in March 2025, with $15 million deployed by the year-end, reflecting our conviction in the Company’s value and ability to deliver consistent performance. Our progress reinforces our confidence that OraSure is well positioned to accelerate our growth as we approach a series of regulatory and commercial milestones in 2026 and continue to transform our business. |
|---|---|
| John P. Kenny Chair of the Board | |
| OraSure’s strategy is overseen by an experienced and engaged Board of Directors whose expertise is aligned with the Company’s priorities for value creation and strong corporate governance. At this year’s Annual Meeting, our Board is seeking shareholder approval for declassification. We believe the annual election of our directors will enhance accountability, independence, and shareholder value.Our journey has been powered by talented and dedicated employees, our loyal customers and partners, our committed stockholders, and the communities we are proud to serve. On behalf of the Board, we thank all of our stakeholders for their continued contributions and investment in OraSure. | |
| Sincerely, | |
| Carrie Eglinton Manner CEO & President | John P. Kenny Chair of Board |
NOTICE OF 2026 ANNUAL MEETING OF STOCKHOLDERS OF ORASURE TECHNOLOGIES, INC.
DATE AND TIME
Wednesday, June 3, 2026
9:00 a.m. (Eastern Time)
To be held virtually by visiting:
http://www.cesonlineservices.com/osur26_vm
ITEMS OF BUSINESS
The 2026 Annual Meeting of Stockholders will be held for the following purposes:
To elect three (3) Class II Directors to serve for a term expiring at the Company’s Annual Meeting of Stockholders in 2029;
To ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026;
To approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement accompanying this Notice;
To approve an amendment and restatement of the Company’s Stock Award Plan to increase the number of shares of Common Stock authorized to be granted under the Plan by 5,000,000 shares and extend its term by an additional ten years; and
To approve an amendment of the Company's Certificate of Incorporation to declassify our Board of Directors and add certain clarifying changes.
HOW TO VOTEVia the Internet. Follow the instructions specified on your proxy card to vote your shares online prior to the Annual Meeting. To participate in the Annual Meeting, you must pre-register at http://www.cesonlineservices.com/osur26_vm by 9:00 a.m. on June 2, 2026, using your control number found on the enclosed proxy card. If you are a holder of record, you may also vote online during the Annual Meeting by going to http://www.cesonlineservices.com/osur26_vm and following the instructions.By Phone. If available, call the toll-free number specified on your enclosed proxy card. Then, follow the unique control number found on the enclosed proxy card.By Mail. You can vote by mail by signing and dating the enclosed proxy card, returning it as indicated on the proxy card. NOTICE OF 2026 ANNUAL MEETING OF STOCKHOLDERS OF ORASURE TECHNOLOGIES, INC.
Who Can Vote: Only holders of shares of the Company’s Common Stock of record at the close of business on April 10, 2026 will be entitled to vote at the Annual Meeting of Stockholders and any adjournment(s) or postponement(s) thereof. Additional information is included in the Proxy Statement accompanying this Notice.
If you have any questions or require any assistance with voting your shares, please contact:
Innisfree M&A Incorporated
501 Madison Avenue, 20th floor
New York, New York 10022
Stockholders may call toll free: (877) 750-8310
Banks and Brokers may call collect: (212) 750-5833
By Order of the Board of Directors,
Stefano Taucer
General Counsel and Corporate Secretary
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.